Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.
Method Article
Orthotopic human liver metastatic uveal melanoma xenograft mouse models were created using surgical orthotopic implantation techniques with patient-derived tumor chunk and needle injection techniques with cultured human uveal melanoma cell lines.
In recent decades, subcutaneously implanted patient-derived xenograft tumors or cultured human cell lines have been increasingly recognized as more representative models to study human cancers in immunodeficient mice than traditional established human cell lines in vitro. Recently, orthotopically implanted patient-derived tumor xenograft (PDX) models in mice have been developed to better replicate features of patient tumors. A liver orthotopic xenograft mouse model is expected to be a useful cancer research platform, providing insights into tumor biology and drug therapy. However, liver orthotopic tumor implantation is generally complicated. Here we describe our protocols for the orthotopic implantation of patient-derived liver-metastatic uveal melanoma tumors. We cultured human liver metastatic uveal melanoma cell lines into immunodeficient mice. The protocols can result in consistently high technical success rates using either a surgical orthotopic implantation technique with chunks of patient-derived uveal melanoma tumor or a needle injection technique with cultured human cell line. We also describe protocols for CT scanning to detect interior liver tumors and for re-implantation techniques using cryopreserved tumors to achieve re-engraftment. Together, these protocols provide a better platform for liver orthotopic tumor mouse models of liver metastatic uveal melanoma in translational research.
Uveal melanoma is the most common intraocular malignant tumor among adults in the western world. During the past 50 years, the incidence of uveal melanoma (5.1 cases per million) has remained stable in the United States1,2. Uveal melanoma arises from melanocytes in the iris, ciliary body, or choroid, and it is an extremely lethal disease when it develops metastasis. The death rate of patients with uveal melanoma metastasis was 80% at 1 year and 92% at 2 years after initial diagnosis of the metastases. The time between diagnosis of metastases and death is typically short, less than 6 months, without regards to therapy3,4. The cancer spreads through the blood and tends to dominantly metastasize to the liver (89-93%)4,5. An effective mouse model is urgently needed for further investigation of liver-metastatic uveal melanoma. For translational research, there is a clear demand to generate a liver-localized metastatic uveal melanoma mouse model.
Patient-derived tumor xenograft (PDX) mouse models are expected to provide individualized medicine strategies. These models might be predictive of clinical outcomes, be useful for preclinical drug evaluation, and be used for biological studies of tumors6. Representative PDX models are ectopically tumor-implanted xenograft mice, which have tumor at subcutaneous sites. Most researchers can do surgery for subcutaneous implantation without special practice7,8. They can also monitor subcutaneous tumors easily. Although subcutaneous PDX models became popular in the research phase, they have some hurdles in moving to practical use. Subcutaneous implantation forces patient-derived tumors to engraft at a different microenvironment from the tumor origin, so that it leads to engraftment failure and slow tumor growth 9,10,11,12,13,14. Orthotopic engraftment may be a more ideal and rational approach for a PDX model because it uses the same organ as the original tumor15,16.
Recently, we developed protocols for surgical orthotopic implantation techniques of patient-derived liver-metastatic uveal melanoma tumors and needle injection techniques with a cultured human liver-metastatic uveal melanoma cell line in NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ (NSG) mice17,18. The protocols result in consistently high technical success rates. We also established CT scanning techniques that are useful to detect interior liver tumors, and we developed re-implantation of cryopreserved tumors in the PDX platform. We found that uveal melanoma tumor xenograft models maintain the characteristics of the original patient liver tumor, including their histopathological and molecular features. Together, these techniques provide a better platform for liver orthotopic tumor models for uveal melanoma in translational research.
Patients enrolled in the study should provide written consent allowing the use of discarded surgical samples for research purposes and genetic studies, according to an Institutional Review Board-approved protocol. This protocol was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health and approved by the Institutional Animal Care and Use Committee (IACUC).
1. Collection of Fresh Patient-derived Tumor Tissue
2. Processing of Fresh Patient-derived Tumor Tissue
3. Surgical Liver Implantation with Patient-derived Tumor Tissue
4. Collecting and Processing of Cultured Human Liver Metastatic Uveal Melanoma Cell Line
5. Surgical Needle Implantation of Cultured Human Liver Metastatic Uveal Melanoma Cell Line into Liver
6. CT Scan
7. Harvesting and Processing Tissue
8. Re-implantation
Surgical orthotopic implantation using the liver pocket method can transplant human liver metastatic uveal melanoma tumor into the mouse liver with a high success rate of 80% within six months. The xenograft tumor engrafts in the liver as a solitary tumor without daughter nodules (Figure 1 and Figure 3A). The surgical orthotopic injection technique into the liver using microneedles successfully engrafted cultured human liver-meta...
The current orthotopic xenograft models are labor-intensive, time-consuming, and expensive to create. Orthotopic tumor xenograft mouse models for liver cancer were established more than two decades ago19,20,21. However, this technique is complicated and requires use of special equipment, such as a micro-needle holder and 6-0 to 8-0 fine sutures under a microscope. Tumor and normal liver tissue must be sewn up carefully so that t...
The authors have nothing to disclose.
We are thankful to M. Ohara, K. Saito, and M. Terai, for reviewing the manuscript. The authors acknowledge critical review for editorial and English assistance of this manuscript by Dr. R. Sato at Fox Chase Cancer Center. The work described herein was supported by the Bonnie Kroll Research Fund, the Mark Weinzierl Research Fund, the Eye Melanoma Research Fund at Thomas Jefferson University, The Osaka Community Foundation, and JSPS KAKENHI Grant Number JP 18K15596 at Osaka City University. Studies in Dr. A. Aplin's laboratory were supported by NIH grant R01 GM067893. This project was also funded by a Dean's Transformative Science Award, a Thomas Jefferson University Programmatic Initiative Award.
Name | Company | Catalog Number | Comments |
Materials, tissues and animals | |||
Buprenorphine | |||
CO2 tank | |||
Cryomedium | |||
Exitron nano 12000 (Alkaline earth metal-based nanoparticle contrast agent) | Miltenyl Biotec | 130-095-700 | |
HBSS 1x, with calcium & magnesium | Corning | 21-020-CM | |
Human liver metastatic uveal melanoma cell line | |||
Human uveal melanoma tissue in the liver | All tissue handling should be done in a Biosafety Level 2 hood. Be careful when working with human tissue; always use gloves and avoid direct skin contact. Assume patients may have been infected with HIV or other highly transmissible organisms. Do not process samples known to carry infections. | ||
Iodine | |||
Isoflurane | Purdue Products | 67618-150-17 | |
Isopropanol | Fisher scientific | A416-1 | Avoid direct contact to skin and eye and inhalation of anesthetic agent. |
Liquid nitrogen | |||
Matrigel HC | BD | 354248 | |
NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ (NSG) mice | Jackson Lab | 5557 | 4 to 8 weeks old |
PBS 1x, without calcium and magnesium | Corning | 21-031-CM | |
RPMI 1640 | Corning | 10-013-CV | |
Sterile alcohol prep pad (70% isopropyl alcohol) | Nice-Pak products | B603 | |
4% paraformaldehyde phosphate buffer solution | Wako | 163-20145 | |
70% Ethyl alcohol solution | Fisher Scientific | 04-355-122 | |
Name | Company | Catalog Number | Comments |
Equipments | |||
Absorbable hemostat | Johnson and Johnson | 63713-0019-61 | |
Autoclave | |||
Body weight measure | |||
Cautery | Bovie Medical | MC-23009 | |
Cell counter | |||
Centrifuzer | |||
Cotton swab | |||
Cryo freezing container | NALGENE | 5100-0001 | |
Cryotube | SARSTEDT | 72.379 | |
Curved scissors | World Precision Instruments | 503247 | |
Curved ultrafine forceps | World Precision Instruments | 501302 | |
Fabric sheet | |||
Freezer | |||
F/AIR Filter Canister | Harvard Apparatus | 600979 | |
Heating pad | |||
Isoflurane vaporizer | Artisan Scientific | 66317-1 | |
Liquid nitrogen | |||
Liquid nitrogen jar | Thermo Fisher Scientific | 2123 | |
Micro-CT scan | Siemens | ||
Needle holder | World Precision Instruments | 501246 | |
Petri dishes | Fisher Scientific | FB0875713 | |
Pipette | |||
Spray bottle | |||
Sterile hood | Biosafety level 2 cabinet | ||
Sterile No.11 scalpel | AD Surgical | A300-11-0 | |
Straight forceps | World Precision Instruments | 14226 | |
Surgical drape | |||
Tail vein restrainer | Braintree Scientific | TV-150-STD | |
Water bath | |||
1 mL TB syringe with 27 G needle | BD | 309623 | |
1.7 mL tube | Bioexpress | C-3260-1 | |
5-0 PDO Suture | AD Surgical | S-D518R13 | |
15 mL conical tubes | AZER SCIENTIFIC | ES-9152N | |
27 G needle | BD | 780301 | |
27 G needle | Hamilton | 7803-01 | |
50 mL conical tubes | AZER SCIENTIFIC | ES-9502N | |
50 µL micro syringe | BD | 80630 | |
50 µL micro syringe | Hamilton | 7655-01 | |
100 mL container | Fisher Scientific | 12594997 | |
200μL tip |
Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE
Zapytaj o uprawnieniaThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone